SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : SMY - SAMSys Technologies Inc -- Ignore unavailable to you. Want to Upgrade?


To: Montana Wildhack who wrote (254)2/19/2004 12:17:58 PM
From: Montana Wildhack  Read Replies (1) | Respond to of 342
 
Food and Drug Administration Report Calls for the Adoption of RFID to Help Secure the Integrity of the Drug Supply Chain
2/18/2004 11:00:00 AM

LAWRENCEVILLE, N. J., Feb 18, 2004 (BUSINESS WIRE) -- In a report issued today, the Food and Drug Administration (FDA) announced that the adoption of Radio Frequency Identification (RFID) by manufacturers, wholesalers and retailers is needed to secure the integrity of the drug supply chain.

The report highlights RFID's ability to track and trace the movement of drug inventory from production to distribution in real time. In addition, the FDA makes note of RFID's ability to make drug counterfeiting extremely difficult and more easily detected.
"EPCglobal applauds the FDA in its support of a global, standards-based approach to tracking prescription drugs," said Dicki Lulay, President, EPCglobal US. "Counterfeit drugs have dangerous implications to patient safety. The tracking and tracing capabilities of the EPCglobal Network will deliver far-reaching benefits for consumers, patients, and the healthcare industry. This added security will allow the industry to deliver an even higher level of patient care."

The EPCglobal Network is an emerging technology that utilizes RFID and Internet technology that enable companies to identify any object anywhere in the global supply chain in real time.

According to the FDA, commercial deployment of RFID and its track and trace capabilities will be feasible by 2007. In the meantime, the FDA is working with sponsors and participants of RFID pilots to address regulatory issues. The FDA is also working with other governmental agencies to coordinate global supply chain activities.

Today's announcement signals continued momentum surrounding the EPCglobal Network and its ability to help secure the integrity of the drug supply chain. In late 2003, the Healthcare Distribution Management Association (HDMA), a nonprofit organization for healthcare distributors, recommended that manufacturers and wholesalers of pharmaceutical drugs begin using RFID tags carrying EPC technology by 2005.

"Pioneers in the industry, like the FDA and HDMA, are helping drive adoption of EPC technologies and illustrate the power and potential of a highly efficient and truly visible supply chain," added Lulay.

About EPCglobal Inc.

EPCglobal Inc., a joint venture between EAN International and the Uniform Code Council (UCC), is a not-for-profit organization entrusted to drive the global, multi-industry adoption and implementation of the EPCglobal Network. EPCglobal Inc. leverages the nearly thirty year heritage of EAN International and the UCC in successfully partnering with industry. The neutral, consensus-based, standards organization aims to make organizations more effective by enabling true visibility of information about items in the supply chain by developing and managing standards for the EPCglobal Network.

EPCglobal US is an affiliate of EPCglobal serving subscribers in the United States to help foster the adoption of the EPCglobal Network and related technology. For more information on EPCglobal Inc., visit the website epcglobalinc.org..

SOURCE: EPCglobal Inc.